EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes

Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho

Endocrinology and Metabolism · 2023

DOI: 10.3803/enm.2023.103 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, 2023. Verfasst von Chang Ho Ahn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Incretins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To maintain normal glucose homeostasis after a meal, it is essential to secrete an adequate amount of insulin from pancreatic β-cells. However, if pancreatic β-cells solely depended on the blood glucose level for insulin secretion, a surge in blood glucose levels would be inevitable after the ingestion of a large amount of carbohydrates. To avoid a deluge of glucose in the bloodstream after a large carbohydrate- rich meal, enteroendocrine cells detect the amount of nutrient absorption from the gut lumen and secrete incretin hormones at scale. Since insulin secretion in response to incretin hormones occurs only in a hyperglycemic milieu, pancreatic β-cells can secrete a “Goldilocks” amount of insulin (i.e., not too much and not too little) to keep the blood glucose level in the normal range. In this regard, pancreatic β-cell sensitivity to glucose and incretin hormones is crucial for maintaining normal glucose homeostasis. In this Namgok lecture 2022, we review the effects of current anti-diabetic medications on pancreatic β-cell sensitivity to glucose and incretin hormones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsDiabetes Mellitus, Type 2HumansBlood GlucoseGlucagon-Like Peptide 1InsulinGastric Inhibitory PolypeptideGlucose

Stichwörter der Autor:innen

Diabetes mellitus, type 2Glucagon-like peptide 1Glucose-dependent insulinotropic polypeptideIncretinsInsulin-secreting cells

Substanzen

IncretinsBlood GlucoseGlucagon-Like Peptide 1InsulinGastric Inhibitory PolypeptideGlucose

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

Zitieren

APA

Ahn, C. H., Oh, T. J., Min, S. H., & Cho, Y. M. (2023). Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2023.103

Vancouver

Ahn CH, Oh TJ, Min SH, Cho YM. Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes. Endocrinology and Metabolism. 2023. doi:10.3803/enm.2023.103

BibTeX
@article{Ahn2023,
  author = {Ahn, Chang Ho and Oh, Tae Jung and Min, Se Hee and Cho, Young Min},
  title = {Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes},
  journal = {Endocrinology and Metabolism},
  year = {2023},
  doi = {10.3803/enm.2023.103}
}
Kostenlos starten →